VAERS reports by lot

Moderna COVID-19 lot 052B22A: VAERS reports

110 VAERS reports list lot 052B22A as a Moderna COVID-19 vaccine, received between 2022-08-02 and 2024-10-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
110
Reports
11%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5030%
Cardiac / Cardiovascular2515%
Gastrointestinal2012%
Neurological1610%
Respiratory1610%
Musculoskeletal95%
Allergic / Anaphylactic85%
Injection-site / Local reaction85%
Dermatological (non-injection-site)64%
Psychiatric / Neuropsychiatric53%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Nevada13
California12
Nebraska9
Minnesota8
Texas7
Michigan7
Tennessee4
Arkansas3
Hawaii2
Puerto Rico2
Montana2
Ohio2

Reports by month received

2022-0818
2022-0942
2022-1018
2022-1110
2022-129
2023-011
2023-022
2023-034
2023-041
2023-071
2023-081
2024-041
2024-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.